SELLAS Life Sciences (SLS) EBITDA Margin (QoQ) (2012 - 2021)
SELLAS Life Sciences (SLS) EBITDA Margin (QoQ) (2012 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
SELLAS Life Sciences |
1.39 Bn |
1.39 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2021 |
-19,498.00 |
| Mar 31, 2021 |
17,951.00 |
| Jun 30, 2015 |
5,550.00 |
| Mar 31, 2015 |
-2,069.00 |
| Dec 31, 2014 |
34,890.00 |
| Sep 30, 2014 |
2,481.00 |
| Jun 30, 2014 |
-13,181.00 |
| Mar 31, 2014 |
-32,622.00 |
| Dec 31, 2013 |
20,643.00 |
| Sep 30, 2013 |
-8,289.00 |
| Jun 30, 2013 |
-3,837.00 |
| Mar 31, 2013 |
-78,099.00 |
| Dec 31, 2012 |
94,923.00 |
